Welcome to LookChem.com Sign In|Join Free

CAS

  • or

185051-07-4

Post Buying Request

185051-07-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

185051-07-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 185051-07-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,0,5 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 185051-07:
(8*1)+(7*8)+(6*5)+(5*0)+(4*5)+(3*1)+(2*0)+(1*7)=124
124 % 10 = 4
So 185051-07-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H12O4/c1-4-8-5-6-9(11(13)15-2)7-10(8)12(14)16-3/h4-7H,1H2,2-3H3

185051-07-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name dimethyl 4-ethenylbenzene-1,3-dicarboxylate

1.2 Other means of identification

Product number -
Other names DIMETHYL 4-VINYLISOPHTHALATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:185051-07-4 SDS

185051-07-4Downstream Products

185051-07-4Relevant articles and documents

Iodine(III)-Mediated Electrochemical Trifluoroethoxylactonisation: Rational Reaction Optimisation and Prediction of Mediator Activity

M?ckel, Robert,Babaoglu, Emre,Hilt, Gerhard

supporting information, p. 15781 - 15785 (2018/10/09)

A new electrochemical iodine(III)-mediated cyclisation reaction for the synthesis of 4-(2,2,2-trifluoroethoxy)isochroman-1-ones is presented. Based on this reaction design of experiments and multivariate linear regression analysis were used to demonstrate

Naaladase inhibitors for treating amyotrophic lateral sclerosis

-

, (2008/06/13)

The present invention relates to pharmaceutical compositions and methods for treating amyotrophic lateral sclerosis using NAALADase inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 185051-07-4